Deep Brain Stimulation (DBS) Retrospective Outcomes Study

NCT03664609 · tracked via the Priya Life Science USA tracker

Sponsor

Boston Scientific Corporation

Phase

Observational

Started

2019-03-12

Last updated

2026-09-03

Condition(s) studied

Parkinson DiseaseEssential TremorDystonia

Investigational drug(s) / intervention(s)

Deep Brain Stimulation

Deep Brain Stimulation: Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.

Study summary

The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Must be previously treated with or eligible for implantation with a deep brain stimulation system Exclusion Criteria: * No Exclusion Criteria

Primary outcome measure(s)

Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline — 5 yrs. post implant
Improvement in disease symptoms as assessed by Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline

Trial sites (20)

Facility	City	Region	Status
St. Joseph's Hospital & Medical Center	Phoenix	Arizona	Recruiting
Riverside University Health System	Moreno Valley	California	Recruiting
University of California, San Francisco	San Francisco	California	Recruiting
University of Miami Hospital	Miami	Florida	Recruiting
University of South Florida	Tampa	Florida	Recruiting
St. Luke's Regional Medical Center	Boise	Idaho	Completed
Albany Medical Center	Albany	New York	Recruiting
Wake Forest University School of Medicine	Winston-Salem	North Carolina	Recruiting
Allegheny General Hospital	Pittsburgh	Pennsylvania	Recruiting
Swedish Neuroscience Institute	Seattle	Washington	Completed
AZ St. Lucas	Ghent	Belgium	Recruiting
AZ Delta	Roeselare	Belgium	Recruiting
Hopital Fondation Adolphe de Rothschild	Paris	France	Recruiting
Uniklinik Köln	Cologne	Germany	Recruiting
Universitaetsklinikum Dusseldorf	Düsseldorf	Germany	Recruiting
Uniklinikum Jena	Jena	Germany	Completed
Universitaetsklinikum Schleswig-Holstein	Lübeck	Germany	Recruiting
Universitaetsklinikum Wuerzburg	Würzburg	Germany	Recruiting
Fondazione Istituto Neurologico Casimiro Mondino	Pavia	Italy	Recruiting
Hospital Virgen Del Rocio	Seville	Spain	Recruiting

More Boston Scientific Corporation trials in the USA

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort Active, not recruiting

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure Recruiting

Patient Retrospective Outcomes (PRO) Recruiting

IT Matters: The Erectile Restoration Registry Enrolling by invitation

Other trials for the same condition

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations Recruiting

Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) Active, not recruiting

Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01 Enrolling by invitation

Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) Active, not recruiting

Abbott DBS Post-Market Study of Outcomes for Indications Over Time Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03664609 on ClinicalTrials.gov ↗ ← All trials in the USA